These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9277810)

  • 1. [Nephrotoxicity of antineoplastic agents (antibiotics)].
    Nakahama H
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):539-41. PubMed ID: 9277810
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity from chemotherapy: prevention and management.
    Vogelzang NJ
    Oncology (Williston Park); 1991 Oct; 5(10):97-102, 105; disc. 105, 109-11. PubMed ID: 1838278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nephrotoxicity of antineoplastic drugs].
    Suzuki T; Nosaka K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
    [No Abstract]   [Full Text] [Related]  

  • 4. Nephrotoxicity of antitumoral agents.
    Fillastre JP; Viotte G; Morin JP; Moulin B
    Adv Nephrol Necker Hosp; 1988; 17():175-218. PubMed ID: 3124539
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mitomycin-induced hemolytic uremia syndrome].
    Steffens F
    Dtsch Med Wochenschr; 2004 Jul; 129(27):1528; author reply 1528. PubMed ID: 15227598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kidney disorders caused by antineoplastic agents].
    Nakabayashi K
    Nihon Naika Gakkai Zasshi; 1994 Oct; 83(10):1734-9. PubMed ID: 7814945
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitomycin C-induced renal insufficiency: a case report.
    Wen MC; Chen CH; Ho WL
    Kaohsiung J Med Sci; 2003 Jun; 19(6):317-21. PubMed ID: 12873041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of erythropoetin on doxorubicin-induced oxidative stress in rat kidney].
    Saenko IuV; Shutov AM; Napalkova SM; Selivanova OS; Evstegneeva EIu
    Eksp Klin Farmakol; 2005; 68(6):52-4. PubMed ID: 16405037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
    Arola O; Aho H; Asola M; Kauppila M; Nikkanen V; Voipio-Pulkki LM
    Duodecim; 1997; 113(19):1923-9. PubMed ID: 10892085
    [No Abstract]   [Full Text] [Related]  

  • 10. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
    Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The renal toxicity of cancer chemotherapeutic agents.
    Weiss RB; Poster DS
    Cancer Treat Rev; 1982 Mar; 9(1):37-56. PubMed ID: 6175410
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrotoxicity of antitumor chemotherapy].
    Cordonnier D; Alix JL; Schaerer R; Swiercz P; Vialtel P; Bayle F
    Presse Med; 1984 Apr; 13(18):1141-5. PubMed ID: 6232549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: mitomycin-induced punctal stenosis.
    Goldstein DA; Tessler HH
    Am J Ophthalmol; 2004 Mar; 137(3):593; author reply 593. PubMed ID: 15013904
    [No Abstract]   [Full Text] [Related]  

  • 14. Doxorubicin-induced cardiomyopathy.
    Muggia FM; Speyer JL
    N Engl J Med; 1999 Feb; 340(8):654-5. PubMed ID: 10049088
    [No Abstract]   [Full Text] [Related]  

  • 15. Unexpected increase in the bone marrow toxicity of mitomycin C (MMC).
    Yoshimoto M; Saito M; Tada T; Kasumi KT
    Br J Cancer; 2001 Mar; 84(5):736-7. PubMed ID: 11237399
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxorubicin-induced cardiomyopathy.
    Swain SM
    N Engl J Med; 1999 Feb; 340(8):654; author reply 655. PubMed ID: 10049087
    [No Abstract]   [Full Text] [Related]  

  • 17. Interstitial pneumonitis: an exceptional toxicity of hyperthermic intraperitoneal mitomycin C.
    González-Moreno S; Lambert LA; Mansfield PF
    Eur J Surg Oncol; 2008 Apr; 34(4):482-4. PubMed ID: 17434283
    [No Abstract]   [Full Text] [Related]  

  • 18. Urethral slough: a rare and previously unreported complication of intravesical mitomycin.
    Brady JD; Assimos DG; Jordan GH
    J Urol; 2000 Oct; 164(4):1305. PubMed ID: 10992392
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilic cystitis presenting as a recurrent symptomatic bladder mass following intravesical mitomycin C therapy.
    Clark T; Chang SS; Cookson MS
    J Urol; 2002 Apr; 167(4):1795. PubMed ID: 11912421
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrosis of the glans penis: a rare complication of intravesical therapy with mitomycin c.
    Neulander EZ; Lismer L; Kaneti J
    J Urol; 2000 Oct; 164(4):1306. PubMed ID: 10992393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.